Steve Schwarzman's Worst Move
Airtime: Thurs. Oct. 21 2010 | 2:00 PM ET
Discussing the worst trade of an otherwise stellar career, with Steve Schwarzman, Blackstone Group’s chairman, CEO & co-founder.

Airtime: Thurs. Oct. 21 2010 | 2:00 PM ET
Discussing the worst trade of an otherwise stellar career, with Steve Schwarzman, Blackstone Group’s chairman, CEO & co-founder.

Study Identifies Heart Risks in Glaxo’s Avandia. Dr. Steven Nissen, of the Cleveland Clinic, authored a controversial study identifying heart risks in GlaxoSmithKline’s Avandia diabetes drug. He talks to CNBC’s Mike Huckman.

Cramer breaks down what he has to say about Fed chief Ben Bernanke.

Insight from Pimco’s Mohamed El-Erian

Airtime: Wed. Feb. 17 2010 | ndard e) ET
The IMF’s move to sell gold in the open market is unlikely to cause a collapse in gold prices, says Sundeep Bhandari, MD & regional head for global markets, Northeast Asia at Standard Chartered. He explains why to CNBC’s Karen Tso & Sri Jegarajah.

A legendary investor weighs in on a new deal, with Wayne Huizenga, Huizenga Holdings chairman/president.

“Barclays has been the lucky bank,” Justin Urquhart Stewart from Seven Investment Management told CNBC Monday when discussing its performance during the credit crisis. Stewart and Allister Heath from CityAM discuss reports that Barclays Capital could develop a partnership model.